Skye Bioscience Inc (SKYE)

[AntonChigurh]

Requirements to uplist to Nasdaq or NYSE

Recently in a interview, CEO Murphy stated that with the proceeds from the Schneider private placement, 'aggressively look to uplist to either NYSE/Nasdaq'. Unlike a lot of OTC/micro-caps companies, when the CEO makes claims I tend to believe him. I wanted to know what is required from NMUS to make this a reality.

http://venturelawcorp.com/listing-requirements-nasdaq/


I don't know what '# Public Board Lot Holders' refers to. Market value (cap?) is 15m, with Schneider exercising their options NMUS is at 30m. But, stock price is something WAY off the requirements.

https://www.nyse.com/publicdocs/nyse/listing/NYSE_Initial_Listing_Standards_Summary.pdf

Similar story, with a bigger market cap required and a MUCH higher shareprice.

Although, I know plenty of securities that are traded on these exchanges with a share price $4>

Anyone have any thoughts or more info?

GLTFA